Cargando…

Measuring school level attributable risk to support school-based HPV vaccination programs

BACKGROUND: In Australia in 2017, 89% of 15-year-old females and 86% of 15-year-old males had received at least one dose of the HPV vaccine. However, considerable variation in HPV vaccination initiation (dose one) across schools remains. It is important to understand the school-level characteristics...

Descripción completa

Detalles Bibliográficos
Autores principales: Vujovich-Dunn, C., Wand, H., Brotherton, J. M. L., Gidding, H., Sisnowski, J., Lorch, R., Veitch, M., Sheppeard, V., Effler, P., Skinner, S. R., Venn, A., Davies, C., Hocking, J., Whop, L., Leask, J., Canfell, K., Sanci, L., Smith, M., Kang, M., Temple-Smith, M., Kidd, M., Burns, S., Selvey, L., Meijer, D., Ennis, S., Thomson, C., Lane, N., Kaldor, J., Guy, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036743/
https://www.ncbi.nlm.nih.gov/pubmed/35468743
http://dx.doi.org/10.1186/s12889-022-13088-x
_version_ 1784693581965950976
author Vujovich-Dunn, C.
Wand, H.
Brotherton, J. M. L.
Gidding, H.
Sisnowski, J.
Lorch, R.
Veitch, M.
Sheppeard, V.
Effler, P.
Skinner, S. R.
Venn, A.
Davies, C.
Hocking, J.
Whop, L.
Leask, J.
Canfell, K.
Sanci, L.
Smith, M.
Kang, M.
Temple-Smith, M.
Kidd, M.
Burns, S.
Selvey, L.
Meijer, D.
Ennis, S.
Thomson, C.
Lane, N.
Kaldor, J.
Guy, R.
author_facet Vujovich-Dunn, C.
Wand, H.
Brotherton, J. M. L.
Gidding, H.
Sisnowski, J.
Lorch, R.
Veitch, M.
Sheppeard, V.
Effler, P.
Skinner, S. R.
Venn, A.
Davies, C.
Hocking, J.
Whop, L.
Leask, J.
Canfell, K.
Sanci, L.
Smith, M.
Kang, M.
Temple-Smith, M.
Kidd, M.
Burns, S.
Selvey, L.
Meijer, D.
Ennis, S.
Thomson, C.
Lane, N.
Kaldor, J.
Guy, R.
author_sort Vujovich-Dunn, C.
collection PubMed
description BACKGROUND: In Australia in 2017, 89% of 15-year-old females and 86% of 15-year-old males had received at least one dose of the HPV vaccine. However, considerable variation in HPV vaccination initiation (dose one) across schools remains. It is important to understand the school-level characteristics most strongly associated with low initiation and their contribution to the overall between-school variation. METHODS: A population-based ecological analysis was conducted using school-level data for 2016 on all adolescent students eligible for HPV vaccination in three Australian jurisdictions. We conducted logistic regression to determine school-level factors associated with lower HPV vaccination initiation (< 75% dose 1 uptake) and estimated the population attributable risk (PAR) and the proportion of schools with the factor (school-level prevalence). RESULTS: The factors most strongly associated with lower initiation, and their prevalence were; small schools (OR = 9.3, 95%CI = 6.1–14.1; 33% of schools), special education schools (OR = 5.6,95%CI = 3.7–8.5; 8% of schools), higher Indigenous enrolments (OR = 2.7,95% CI:1.9–3.7; 31% of schools), lower attendance rates (OR = 2.6,95%CI = 1.7–3.7; 35% of schools), remote location (OR = 2.6,95%CI = 1.6–4.3; 6% of schools,) and lower socioeconomic area (OR = 1.8,95% CI = 1.3–2.5; 33% of schools). The highest PARs were small schools (PAR = 79%, 95%CI:76–82), higher Indigenous enrolments (PAR = 38%, 95%CI: 31–44) and lower attendance rate (PAR = 37%, 95%CI: 29–46). CONCLUSION: This analysis suggests that initiatives to support schools that are smaller, with a higher proportion of Indigenous adolescents and lower attendance rates may contribute most to reducing the variation of HPV vaccination uptake observed at a school-level in these jurisdictions. Estimating population-level coverage at the school-level is useful to guide policy and prioritise resourcing to support school-based vaccination programs. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-022-13088-x.
format Online
Article
Text
id pubmed-9036743
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-90367432022-04-26 Measuring school level attributable risk to support school-based HPV vaccination programs Vujovich-Dunn, C. Wand, H. Brotherton, J. M. L. Gidding, H. Sisnowski, J. Lorch, R. Veitch, M. Sheppeard, V. Effler, P. Skinner, S. R. Venn, A. Davies, C. Hocking, J. Whop, L. Leask, J. Canfell, K. Sanci, L. Smith, M. Kang, M. Temple-Smith, M. Kidd, M. Burns, S. Selvey, L. Meijer, D. Ennis, S. Thomson, C. Lane, N. Kaldor, J. Guy, R. BMC Public Health Research BACKGROUND: In Australia in 2017, 89% of 15-year-old females and 86% of 15-year-old males had received at least one dose of the HPV vaccine. However, considerable variation in HPV vaccination initiation (dose one) across schools remains. It is important to understand the school-level characteristics most strongly associated with low initiation and their contribution to the overall between-school variation. METHODS: A population-based ecological analysis was conducted using school-level data for 2016 on all adolescent students eligible for HPV vaccination in three Australian jurisdictions. We conducted logistic regression to determine school-level factors associated with lower HPV vaccination initiation (< 75% dose 1 uptake) and estimated the population attributable risk (PAR) and the proportion of schools with the factor (school-level prevalence). RESULTS: The factors most strongly associated with lower initiation, and their prevalence were; small schools (OR = 9.3, 95%CI = 6.1–14.1; 33% of schools), special education schools (OR = 5.6,95%CI = 3.7–8.5; 8% of schools), higher Indigenous enrolments (OR = 2.7,95% CI:1.9–3.7; 31% of schools), lower attendance rates (OR = 2.6,95%CI = 1.7–3.7; 35% of schools), remote location (OR = 2.6,95%CI = 1.6–4.3; 6% of schools,) and lower socioeconomic area (OR = 1.8,95% CI = 1.3–2.5; 33% of schools). The highest PARs were small schools (PAR = 79%, 95%CI:76–82), higher Indigenous enrolments (PAR = 38%, 95%CI: 31–44) and lower attendance rate (PAR = 37%, 95%CI: 29–46). CONCLUSION: This analysis suggests that initiatives to support schools that are smaller, with a higher proportion of Indigenous adolescents and lower attendance rates may contribute most to reducing the variation of HPV vaccination uptake observed at a school-level in these jurisdictions. Estimating population-level coverage at the school-level is useful to guide policy and prioritise resourcing to support school-based vaccination programs. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-022-13088-x. BioMed Central 2022-04-25 /pmc/articles/PMC9036743/ /pubmed/35468743 http://dx.doi.org/10.1186/s12889-022-13088-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Vujovich-Dunn, C.
Wand, H.
Brotherton, J. M. L.
Gidding, H.
Sisnowski, J.
Lorch, R.
Veitch, M.
Sheppeard, V.
Effler, P.
Skinner, S. R.
Venn, A.
Davies, C.
Hocking, J.
Whop, L.
Leask, J.
Canfell, K.
Sanci, L.
Smith, M.
Kang, M.
Temple-Smith, M.
Kidd, M.
Burns, S.
Selvey, L.
Meijer, D.
Ennis, S.
Thomson, C.
Lane, N.
Kaldor, J.
Guy, R.
Measuring school level attributable risk to support school-based HPV vaccination programs
title Measuring school level attributable risk to support school-based HPV vaccination programs
title_full Measuring school level attributable risk to support school-based HPV vaccination programs
title_fullStr Measuring school level attributable risk to support school-based HPV vaccination programs
title_full_unstemmed Measuring school level attributable risk to support school-based HPV vaccination programs
title_short Measuring school level attributable risk to support school-based HPV vaccination programs
title_sort measuring school level attributable risk to support school-based hpv vaccination programs
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036743/
https://www.ncbi.nlm.nih.gov/pubmed/35468743
http://dx.doi.org/10.1186/s12889-022-13088-x
work_keys_str_mv AT vujovichdunnc measuringschoollevelattributablerisktosupportschoolbasedhpvvaccinationprograms
AT wandh measuringschoollevelattributablerisktosupportschoolbasedhpvvaccinationprograms
AT brothertonjml measuringschoollevelattributablerisktosupportschoolbasedhpvvaccinationprograms
AT giddingh measuringschoollevelattributablerisktosupportschoolbasedhpvvaccinationprograms
AT sisnowskij measuringschoollevelattributablerisktosupportschoolbasedhpvvaccinationprograms
AT lorchr measuringschoollevelattributablerisktosupportschoolbasedhpvvaccinationprograms
AT veitchm measuringschoollevelattributablerisktosupportschoolbasedhpvvaccinationprograms
AT sheppeardv measuringschoollevelattributablerisktosupportschoolbasedhpvvaccinationprograms
AT efflerp measuringschoollevelattributablerisktosupportschoolbasedhpvvaccinationprograms
AT skinnersr measuringschoollevelattributablerisktosupportschoolbasedhpvvaccinationprograms
AT venna measuringschoollevelattributablerisktosupportschoolbasedhpvvaccinationprograms
AT daviesc measuringschoollevelattributablerisktosupportschoolbasedhpvvaccinationprograms
AT hockingj measuringschoollevelattributablerisktosupportschoolbasedhpvvaccinationprograms
AT whopl measuringschoollevelattributablerisktosupportschoolbasedhpvvaccinationprograms
AT leaskj measuringschoollevelattributablerisktosupportschoolbasedhpvvaccinationprograms
AT canfellk measuringschoollevelattributablerisktosupportschoolbasedhpvvaccinationprograms
AT sancil measuringschoollevelattributablerisktosupportschoolbasedhpvvaccinationprograms
AT smithm measuringschoollevelattributablerisktosupportschoolbasedhpvvaccinationprograms
AT kangm measuringschoollevelattributablerisktosupportschoolbasedhpvvaccinationprograms
AT templesmithm measuringschoollevelattributablerisktosupportschoolbasedhpvvaccinationprograms
AT kiddm measuringschoollevelattributablerisktosupportschoolbasedhpvvaccinationprograms
AT burnss measuringschoollevelattributablerisktosupportschoolbasedhpvvaccinationprograms
AT selveyl measuringschoollevelattributablerisktosupportschoolbasedhpvvaccinationprograms
AT meijerd measuringschoollevelattributablerisktosupportschoolbasedhpvvaccinationprograms
AT enniss measuringschoollevelattributablerisktosupportschoolbasedhpvvaccinationprograms
AT thomsonc measuringschoollevelattributablerisktosupportschoolbasedhpvvaccinationprograms
AT lanen measuringschoollevelattributablerisktosupportschoolbasedhpvvaccinationprograms
AT kaldorj measuringschoollevelattributablerisktosupportschoolbasedhpvvaccinationprograms
AT guyr measuringschoollevelattributablerisktosupportschoolbasedhpvvaccinationprograms